| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PROVECTUS BIOPHARMACEUTICALS, INC. | Director | Stock Options (Right to Buy) | 775,082 | 02 Dec 2024 | Direct | ||
| PROVECTUS BIOPHARMACEUTICALS, INC. | Director | Series D-1 Convertible Preferred Stock | 179,592 | 30 Sep 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | 02 Dec 2024 | 1 | $0 | 4 | Director | 04 Dec 2024, 21:49 |
| PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | 30 Sep 2024 | 1 | $0 | 4 | Director | 30 Sep 2024, 20:01 |